J Palliat Med. 2010 Jul;13(7):903-8.

Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care.

Source

Institute for Palliative Medicine at San Diego Hospice, Palliative Care Psychiatry, San Diego, California 92103, USA. sirwin@sdhospice.org

Abstract

Depression is prevalent and undertreated in patients receiving hospice care. Standard antidepressants do not work rapidly or often enough to benefit most of these patients. Here, two cases are reported in which a single oral dose of ketamine provided rapid and moderately sustained symptom relief for both depression and anxiety. In addition, no adverse effects were noted. Further investigation with randomized, controlled clinical trials is necessary to firmly establish the effectiveness of oral ketamine for the treatment of depression and anxiety in patients receiving hospice care. Ketamine may be a promising safe, effective, and cost-effective rapid treatment for depression and anxiety in this population.

PMID:: 20636166; [PubMed - indexed for MEDLINE]
PMCID:: PMC3120058

Free PMC Article

Images from this publication.See all images (2) Free text

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

Case Reports

MeSH Terms

Substances

Grant Support

K23 MH091176-02/MH/NIMH NIH HHS/United States

LinkOut - more resources

Full Text Sources

Supplemental Content

Related citations

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. [Arch Gen Psychiatry. 2006]
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK. Arch Gen Psychiatry. 2006 Aug; 63(8):856-64.
Sertraline effectiveness and safety in depressed oncological patients. [Support Care Cancer. 2008]
Sertraline effectiveness and safety in depressed oncological patients.
Torta R, Siri I, Caldera P. Support Care Cancer. 2008 Jan; 16(1):83-91. Epub 2007 Sep 14.
Review Moclobemide: therapeutic use and clinical studies. [CNS Drug Rev. 2003]
Review Moclobemide: therapeutic use and clinical studies.
Bonnet U. CNS Drug Rev. 2003 Spring; 9(1):97-140.
The use of a series of ketamine infusions in two patients with treatment-resistant depression. [J Neuropsychiatry Clin Neurosc...]
The use of a series of ketamine infusions in two patients with treatment-resistant depression.
Messer M, Haller IV, Larson P, Pattison-Crisostomo J, Gessert CE. J Neuropsychiatry Clin Neurosci. 2010 Fall; 22(4):442-4.
Review Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. [J Affect Disord. 1998]
Review Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression.
Fawcett J, Barkin RL. J Affect Disord. 1998 Dec; 51(3):267-85.

See reviews... See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
References for this PMC Article
Citation referenced in PubMed article. Only valid for PubMed citations that are also in PMC.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Free in PMC
Free full text articles in PMC

Recent activity

Clear Turn Off Turn On

Oral ketamine for the rapid treatment of depression and anxiety in patients rece...
Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care.
J Palliat Med. 2010 Jul ;13(7):903-8.

PubMed
Reward, addiction, and emotion regulation systems associated with rejection in l...
Reward, addiction, and emotion regulation systems associated with rejection in love.
J Neurophysiol. 2010 Jul ;104(1):51-60. Epub 2010 May 5 .

PubMed
Frontal-striatal dysfunction during planning in obsessive-compulsive disorder.
Frontal-striatal dysfunction during planning in obsessive-compulsive disorder.
Arch Gen Psychiatry. 2005 Mar ;62(3):301-9.

PubMed
Neural correlates of cognitive inflexibility during task-switching in obsessive-...
Neural correlates of cognitive inflexibility during task-switching in obsessive-compulsive disorder.
Brain. 2008 Jan ;131(Pt 1):155-64. Epub 2007 Dec 7 .

PubMed
Alone but feeling no pain: Effects of social exclusion on physical pain toleranc...
Alone but feeling no pain: Effects of social exclusion on physical pain tolerance and pain threshold, affective forecasting, and interpersonal empathy.
J Pers Soc Psychol. 2006 Jul ;91(1):1-15.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to:

Oral ketamine for the rapid treatment of depression and anxiety in patients receiving hospice care.

Source

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Related citations

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information